FDA issues draft guidance on developing drugs for acromegaly
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesClinical TrialsComplianceNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyRegulatory NewsJoanne S. EglovitchBiologics/ biosimilars/ vaccinesClinical TrialsComplianceNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy